| Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study FS Dawood, AD Iuliano, C Reed, MI Meltzer, DK Shay, PY Cheng, ... The Lancet infectious diseases 12 (9), 687-695, 2012 | 1773 | 2012 |
| Re-evaluating the burden of rabies in Africa and Asia DL Knobel, S Cleaveland, PG Coleman, EM Fèvre, MI Meltzer, ... Bulletin of the World health Organization 83, 360-368, 2005 | 1772 | 2005 |
| The economic impact of pandemic influenza in the United States: priorities for intervention. MI Meltzer, NJ Cox, K Fukuda Emerging infectious diseases 5 (5), 659, 1999 | 1054 | 1999 |
| Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial CB Bridges, WW Thompson, MI Meltzer, GR Reeve, WJ Talamonti, ... Jama 284 (13), 1655-1663, 2000 | 973 | 2000 |
| The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? AF Kaufmann, MI Meltzer, GP Schmid Emerging infectious diseases 3 (2), 83, 1997 | 706 | 1997 |
| Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance J Morgan, MI Meltzer, BD Plikaytis, AN Sofair, S Huie-White, S Wilcox, ... Infection control & hospital epidemiology 26 (6), 540-547, 2005 | 564 | 2005 |
| Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009–April 2010) SS Shrestha, DL Swerdlow, RH Borse, VS Prabhu, L Finelli, CY Atkins, ... Clinical Infectious Diseases 52 (suppl_1), S75-S82, 2011 | 559 | 2011 |
| Human rabies prevention-United states, 2008 SE Manning, CE Rupprecht, D Fishbein, CA Hanlon, B Lumlertdacha, ... MMWR Recomm Rep 57, 1-28, 2008 | 530 | 2008 |
| Estimating the future number of cases in the Ebola epidemic—Liberia and Sierra Leone, 2014–2015 MI Meltzer, CY Atkins, S Santibanez, B Knust, BW Petersen, ED Ervin, ... MMWR Surveill Summ 63 (Suppl 3), 1-14, 2014 | 497 | 2014 |
| Estimates of US influenza‐associated deaths made using four different methods WW Thompson, E Weintraub, P Dhankhar, PY Cheng, L Brammer, ... Influenza and other respiratory viruses 3 (1), 37-49, 2009 | 496 | 2009 |
| Estimates of the prevalence of pandemic (H1N1) 2009, United States, April–July 2009 C Reed, FJ Angulo, DL Swerdlow, M Lipsitch, MI Meltzer, D Jernigan, ... Emerging infectious diseases 15 (12), 2004, 2009 | 447 | 2009 |
| Impact of dengue/dengue hemorrhagic fever on the developing world DJ Gubler, M Meltzer Advances in virus research 53, 35-70, 1999 | 446 | 1999 |
| Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices CE Rupprecht, D Briggs, CM Brown, R Franka, SL Katz, HD Kerr, SM Lett, ... MMWR Recomm Rep 59 (RR-2), 1-9, 2010 | 418 | 2010 |
| Estimating influenza disease burden from population-based surveillance data in the United States C Reed, SS Chaves, P Daily Kirley, R Emerson, D Aragon, EB Hancock, ... PloS one 10 (3), e0118369, 2015 | 405 | 2015 |
| Modeling potential responses to smallpox as a bioterrorist weapon. MI Meltzer, I Damon, JW LeDuc, JD Millar Emerging infectious diseases 7 (6), 959, 2001 | 345 | 2001 |
| Introduction to health economics for physicians MI Meltzer The Lancet 358 (9286), 993-998, 2001 | 286 | 2001 |
| Cost-effectiveness and potential impact of rotavirus vaccination in the United States MA Widdowson, MI Meltzer, X Zhang, JS Bresee, UD Parashar, RI Glass Pediatrics 119 (4), 684-697, 2007 | 285 | 2007 |
| Glaucoma’s impact on quality of life and its relation to clinical indicators: a pilot study MB Sherwood, A Garcia-Siekavizza, MI Meltzer, A Hebert, AF Burns, ... Ophthalmology 105 (3), 561-566, 1998 | 285 | 1998 |
| Microneedle patches: usability and acceptability for self-vaccination against influenza JJ Norman, JM Arya, MA McClain, PM Frew, MI Meltzer, MR Prausnitz Vaccine 32 (16), 1856-1862, 2014 | 278 | 2014 |
| Influenza cost and cost-effectiveness studies globally–a review SK Peasah, E Azziz-Baumgartner, J Breese, MI Meltzer, MA Widdowson Vaccine 31 (46), 5339-5348, 2013 | 258 | 2013 |
David L. Swerdlow, MDHarvard School of Public HealthVerified email at hsph.harvard.edu
